1. Home
  2. KRT vs IMMX Comparison

KRT vs IMMX Comparison

Compare KRT & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Karat Packaging Inc.

KRT

Karat Packaging Inc.

HOLD

Current Price

$27.19

Market Cap

534.4M

Sector

Industrials

ML Signal

HOLD

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$8.83

Market Cap

629.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRT
IMMX
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
534.4M
629.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KRT
IMMX
Price
$27.19
$8.83
Analyst Decision
Sell
Strong Buy
Analyst Count
2
5
Target Price
$26.50
$19.20
AVG Volume (30 Days)
94.0K
1.2M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
6.33%
N/A
EPS Growth
4.70
N/A
EPS
0.34
N/A
Revenue
$467,743,000.00
N/A
Revenue This Year
$13.05
N/A
Revenue Next Year
$8.11
N/A
P/E Ratio
$80.50
N/A
Revenue Growth
10.67
N/A
52 Week Low
$20.61
$1.87
52 Week High
$32.06
$11.61

Technical Indicators

Market Signals
Indicator
KRT
IMMX
Relative Strength Index (RSI) 46.87 42.84
Support Level $26.95 $8.10
Resistance Level $30.82 $8.97
Average True Range (ATR) 0.88 0.72
MACD -0.03 -0.11
Stochastic Oscillator 55.77 27.31

Price Performance

Historical Comparison
KRT
IMMX

About KRT Karat Packaging Inc.

Karat Packaging Inc is a distributor and manufacturer of disposable foodservice products and related items, including containers, bags, tableware, cups, lids, cutlery, straws, specialty beverage ingredients, gloves, and janitorial supplies, available in plastic, paper, biopolymer-based, and other compostable forms. The Company focuses on environmentally friendly products and provides customized solutions including product development, design, printing, and logistics services. It serves customers through chains and distributors, retail, and e-commerce/online, and operates in the manufacturing and distribution of single-use food and beverage products, as well as specialty food and beverage products and restaurant and warehouse supplies.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: